Adaptive Biotechnologies and Microsoft are studying COVID-19 in an expansion of their collaboration, which focuses on mapping population-wide adaptive immune responses to diseases at scale, and to share the data they gather on the virus publicly. [Adaptive Biotechnologies]
Adaptive Biotechnologies and Microsoft expect to have samples sequenced in June from their expanded collaboration to map population-wide adaptive immune responses to COVID-19, with plans to share their data publicly . . .